These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23180494)

  • 1. [Why choose another cholinesterase inhibitor than donepezil?].
    Lindberg OM
    Ugeskr Laeger; 2012 Sep; 174(39):2331. PubMed ID: 23180494
    [No Abstract]   [Full Text] [Related]  

  • 2. Donepezil and Alzheimer's dementia.
    Earl-Slater A; Walley T
    Clin Perform Qual Health Care; 2000; 8(1):47-51. PubMed ID: 11183967
    [No Abstract]   [Full Text] [Related]  

  • 3. Donepezil in the treatment of dementia with lewy bodies.
    Beversdorf DQ; Warner JL; Davis RA; Sharma UK; Nagaraja HN; Scharre DW
    Am J Geriatr Psychiatry; 2004; 12(5):542-4. PubMed ID: 15353396
    [No Abstract]   [Full Text] [Related]  

  • 4. Emergent complications following donepezil switchover to galantamine in three cases of dementia with Lewy bodies.
    Bhanji NH; Gauthier S
    J Neuropsychiatry Clin Neurosci; 2005; 17(4):552-5. PubMed ID: 16387998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Questions about donepezil.
    Elie LM; Cole MG
    CMAJ; 1998 Apr; 158(8):1014-5. PubMed ID: 9580729
    [No Abstract]   [Full Text] [Related]  

  • 6. Advertisements for donepezil. Prices charged for private prescriptions for donepezil show huge variation.
    Jones RW; Mann JB; Saunders SA
    BMJ; 1997 Dec; 315(7122):1624. PubMed ID: 9437306
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome induced by donepezil.
    Matsumoto T; Kawanishi C; Isojima D; Iseki E; Kishida I; Kosaka K
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):101-3. PubMed ID: 14731314
    [No Abstract]   [Full Text] [Related]  

  • 8. Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia.
    Alwahhabi FK
    J Psychopharmacol; 2005 Mar; 19(2):214-6. PubMed ID: 15728444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S; Hill J; Fillit H
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donepezil-induced sleep spindle in a patient with dementia with Lewy bodies: a case report.
    Ozaki A; Nishida M; Koyama K; Ishikawa K; Nishikawa T
    Psychogeriatrics; 2012 Dec; 12(4):255-8. PubMed ID: 23279148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
    Thomas AJ; Burn DJ; Rowan EN; Littlewood E; Newby J; Cousins D; Pakrasi S; Richardson J; Sanders J; McKeith IG
    Int J Geriatr Psychiatry; 2005 Oct; 20(10):938-44. PubMed ID: 16163744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donepezil for the treatment of psychosis in dementia with Lewy bodies.
    Fergusson E; Howard R
    Int J Geriatr Psychiatry; 2000 Mar; 15(3):280-1. PubMed ID: 10713588
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of Donepezil on Extrapyramidal Symptoms in Patients with Dementia with Lewy Bodies: A Secondary Pooled Analysis of Two Randomized-Controlled and Two Open-Label Long-Term Extension Studies.
    Mori E; Ikeda M; Nakagawa M; Miyagishi H; Yamaguchi H; Kosaka K
    Dement Geriatr Cogn Disord; 2015; 40(3-4):186-98. PubMed ID: 26226884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
    Minett TS; Thomas A; Wilkinson LM; Daniel SL; Sanders J; Richardson J; Littlewood E; Myint P; Newby J; McKeith IG
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation.
    Anzellotti F; Bonanni L; Iorio E; Di Baldassarre F; D'Andreagiovanni A; Monaco D; Thomas A; Onofrj M
    Clin Neuropharmacol; 2008; 31(4):231-7. PubMed ID: 18670247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful use of donepezil for the treatment of dementia with Lewy bodies.
    Rojas-Fernandez CH
    Ann Pharmacother; 2001 Feb; 35(2):202-5. PubMed ID: 11215841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study.
    Mori S; Mori E; Iseki E; Kosaka K
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):190-5. PubMed ID: 16594943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diffuse Lewy body disease].
    Kosaka K
    Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1414-8. PubMed ID: 13677888
    [No Abstract]   [Full Text] [Related]  

  • 20. The use, benefits, and costs of cholinesterase inhibitors for Alzheimer's dementia in long-term care: are the data relevant and available?
    Khang P; Weintraub N; Espinoza RT
    J Am Med Dir Assoc; 2004; 5(4):249-55. PubMed ID: 15228635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.